Lisa Rojkjaer

Chief Medical Officer, Viracta Therapeutics, Inc.

Companies

RIGEL PHARMACEUTICALS INCEVP, Chief Medical Officer Mar 29, 2024 to now¹
Viracta Therapeutics, Inc.Chief Medical Officer Feb 24, 2021 to Mar 17, 2023²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 1, 2026Shares withheld for tax 850 shares at $29.86 of RIGEL PHARMACEUTICALS INC³
Feb 17, 2026Granted 18,894 shares of RIGEL PHARMACEUTICALS INC⁵
Feb 10, 2026Shares withheld for tax 3,758 shares at $34.62 of RIGEL PHARMACEUTICALS INC⁶
Jan 29, 2025Granted 19,717 shares of RIGEL PHARMACEUTICALS INC⁷
Feb 27, 2023Sold 2,156 shares at $1.68 of Viracta Therapeutics, Inc.⁴
Feb 25, 2023Exercised options 4,127 shares of Viracta Therapeutics, Inc.⁴
Nov 28, 2022Sold 2,116 shares at $2.72 of Viracta Therapeutics, Inc.⁸
Nov 25, 2022Exercised options 4,127 shares of Viracta Therapeutics, Inc.⁸
Aug 26, 2022Sold 2,190 shares at $4.01 of Viracta Therapeutics, Inc.⁹
Aug 25, 2022Exercised options 4,127 shares of Viracta Therapeutics, Inc.⁹
May 26, 2022Sold 2,154 shares at $1.90 of Viracta Therapeutics, Inc.¹⁰
May 25, 2022Exercised options 4,127 shares of Viracta Therapeutics, Inc.¹⁰
Feb 28, 2022Sold 2,395 shares at $2.78 of Viracta Therapeutics, Inc.¹¹
Feb 25, 2022Exercised options 4,127 shares of Viracta Therapeutics, Inc.¹¹
Nov 29, 2021Sold 2,591 shares at $4.82 of Viracta Therapeutics, Inc.¹²
Nov 26, 2021Sold 1,950 shares at $4.80 of Viracta Therapeutics, Inc.¹²
Nov 25, 2021Exercised options 8,254 shares of Viracta Therapeutics, Inc.¹²

The numbers on this page point here. Each one links to the record it came from.